Impact of Lipid-lowering Drug Target Perturbation on Risk of Thyroid Dysfunction: A Mendelian Randomization Study

Name: Impact of Lipid-lowering Drug Target Perturbation on Risk of Thyroid Dysfunction: A Mendelian Randomization Study
Creator: Shantou University Medical College; Shantou University
License: 暂无描述

Mendeley Data2026-04-09 收录

下载链接：

https://data.mendeley.com/datasets/bp3jcnfmw8

下载链接

链接失效反馈

官方服务：

资源简介：

Supplementary Materials

提供机构：

Shantou University Medical College; Shantou University

Impact of Lipid-lowering Drug Target Perturbation on Risk of Thyroid Dysfunction: A Mendelian Randomization Study

Supplementary Materials

NIAID Data Ecosystem10

Genetic variation in targets of lipid-lowering drugs and amyotrophic lateral sclerosis risk: a Mendelian randomization study

The use of lipid-lowering drugs is still highly controversial in patients with amyotrophic lateral sclerosis (ALS). We performed a drug-target Mendelian randomization (MR) analysis to investigate the

DataCite Commons2024-03-04 更新20

Genetic variation in targets of lipid-lowering drugs and amyotrophic lateral sclerosis risk: a Mendelian randomization study

The use of lipid-lowering drugs is still highly controversial in patients with amyotrophic lateral sclerosis (ALS). We performed a drug-target Mendelian randomization (MR) analysis to investigate the

NIAID Data Ecosystem00

Investigating the potential impact of lipid-lowering drugs on thyroid dysfunction: a Mendelian randomization study

Supplementary Materials

Mendeley Data10

Genetic variation in targets of lipid-lowering drugs and amyotrophic lateral sclerosis risk: a Mendelian randomization study

The use of lipid-lowering drugs is still highly controversial in patients with amyotrophic lateral sclerosis (ALS). We performed a drug-target Mendelian randomization (MR) analysis to investigate the

DataCite Commons2024-03-04 更新80